Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation
- PMID: 18591386
- PMCID: PMC2518496
- DOI: 10.2337/db07-1820
Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation
Abstract
Objective: To determine whether interindividual heterogeneity in the erythrocyte (red blood cell [RBC]) transmembrane glucose gradient might explain discordances between A1C and glycemic control based on measured fructosamine.
Research design and methods: We modeled the relationship between plasma glucose and RBC glucose as the concentration distribution (C(i)-to-C(o) ratio) of a nonmetabolizable glucose analog (14)C-3-O-methyl glucose ((14)C-3OMG) inside (C(i)) and outside (C(o)) RBCs in vitro. We examined the relationship between that distribution and the degree of glycation of hemoglobin in comparison with glycation of serum proteins (fructosamine), the glycation gap. A1C, fructosamine, and in vitro determination of the (14)C-3OMG distribution in glucose-depleted RBCs were measured in 26 fasted subjects.
Results: The C(i)-to-C(o) ratio 0.89 +/- 0.07 for 3-O-methyl-d-glucopyranose (3OMG) ranged widely (0.72-1.04, n = 26). In contrast, urea C(i)-to-C(o) (1.015 +/- 0.022 [range 0.98-1.07], P < 0.0001) did not. Concerning mechanism, in a representative subset of subjects, the C(i)-to-C(o) ratio was retained in RBC ghosts, was not dependent on ATP or external cations, and was reestablished after reversal of the glucose gradient. The 3OMG C(i)-to-C(o) ratio was not correlated with serum fructosamine, suggesting that it was independent of mean plasma glucose. However, C(i)-to-C(o) did correlate with A1C (R(2) = 0.19) and with the glycation gap (R(2) = 0.20), consistent with a model in which differences in internal glucose concentration at a given mean plasma glucose contribute to differences in A1C for given level of glycemic control.
Conclusions: The data demonstrate interindividual heterogeneity in glucose gradients across RBC membranes that may affect hemoglobin glycation and have implications for diabetes complications risk and risk assessment.
Figures
Similar articles
-
Transmembrane electron transfer in diabetic nephropathy.Diabetes Care. 2000 Jul;23(7):994-9. doi: 10.2337/diacare.23.7.994. Diabetes Care. 2000. PMID: 10895853
-
The ratio of estimated average glucose to fasting plasma glucose level is superior to glycated albumin, hemoglobin A1c, fructosamine, and GA/A1c ratio for assessing β-cell function in childhood diabetes.Biomed Res Int. 2014;2014:370790. doi: 10.1155/2014/370790. Epub 2014 Jun 10. Biomed Res Int. 2014. PMID: 25013775 Free PMC article.
-
Variable glycation of serum proteins in patients with diabetes mellitus.Clin Invest Med. 1997 Apr;20(2):103-9. Clin Invest Med. 1997. PMID: 9088666
-
Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring.J Diabetes Complications. 2020 Aug;34(8):107585. doi: 10.1016/j.jdiacomp.2020.107585. Epub 2020 Apr 23. J Diabetes Complications. 2020. PMID: 32553575 Review.
-
Misleading hemoglobin A1c levels in a patient with paroxysmal nocturnal hemoglobinuria.Am J Clin Pathol. 2014 Aug;142(2):261-5. doi: 10.1309/AJCPTK1HPR2KULJU. Am J Clin Pathol. 2014. PMID: 25015870 Review.
Cited by
-
Physiologic Concepts That May Revise the Interpretation and Implications of HbA1C in Clinical Medicine: An American Perspective.J Diabetes Sci Technol. 2015 May;9(3):696-700. doi: 10.1177/1932296815572255. Epub 2015 Feb 17. J Diabetes Sci Technol. 2015. PMID: 25691656 Free PMC article.
-
Racial disparity in HbA1c persists when fructosamine is used as a surrogate for mean blood glucose in youth with type 1 diabetes.Pediatr Diabetes. 2018 Nov;19(7):1243-1248. doi: 10.1111/pedi.12696. Epub 2018 Aug 21. Pediatr Diabetes. 2018. PMID: 29808574 Free PMC article.
-
Current therapeutic approaches in the management of hyperglycemia in chronic renal disease.Rev Endocr Metab Disord. 2017 Mar;18(1):5-19. doi: 10.1007/s11154-017-9416-1. Rev Endocr Metab Disord. 2017. PMID: 28258533 Review.
-
When the blood glucose and the HbA(1c) don't match: turning uncertainty into opportunity.Diabetes Care. 2012 Dec;35(12):2421-3. doi: 10.2337/dc12-1479. Diabetes Care. 2012. PMID: 23173128 Free PMC article. No abstract available.
-
Glucoregulatory function among African Americans and European Americans with normal or pre-diabetic hemoglobin A1c levels.Metabolism. 2014 Jun;63(6):767-72. doi: 10.1016/j.metabol.2014.03.002. Epub 2014 Mar 5. Metabolism. 2014. PMID: 24641885 Free PMC article.
References
-
- Hempe JM, Gomez R, McCarterRJ, Jr, Chalew SA: High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 16 :313 –320,2002 - PubMed
-
- Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ: Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 33 :208 –215,1990 - PubMed
-
- Gould BJ, Davie SJ, Yudkin JS: Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clin Chim Acta 260 :49 –64,1997 - PubMed
-
- Cohen RM, Holmes YR, Chenier TC, Joiner CH: Discordance between A1C and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 26 :163 –167,2003 - PubMed
-
- Cohen RM, LeCaire TJ, Lindsell CJ, Smith EP, D'Alessio DJ: The relationship of prospective glycated hemoglobin to glycated serum proteins in incident diabetic retinopathy: implications of the glycation gap for mechanism of risk prediction. Diabetes Care 31 :151 –153,2007 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
